GSK raises $1B+ from selling shares in consumer health spinoff Haleon
GSK is selling off part of its stake in its consumer health spinoff Haleon, raising gross proceeds of approximately $1 billion (£804 million), the company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.